Protagenic therapeutics schedules first q4 and fy 2023 earnings call

Call scheduled for monday, april 1st, 2024, at 4:30 pm et new york, ny / accesswire / march 25, 2024 / protagenic therapeutics, inc. (nasdaq:ptix), a biopharmaceutical innovator, announced that the company plans to hold its first investor earnings call to discuss the results contained in its fy 2023 form 10k, which it plans to file that day, and its outlook for fy 2024. the company plans to hold its earnings call, open to the public, at 4:30 pm et on monday, april 1st, to discuss the results of its q4 and fy 2023, which it plans to publish in its form 10k to be filed with the sec that day.
PTIX Ratings Summary
PTIX Quant Ranking